Related Experiment Video
Updated: Jul 3, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Comparison of Typical and Atypical Community Acquired Pneumonia Cases in Hospitalized Patients in Two Tertiary
Abdullah Almufleh1, Abdulrahman Altuwayjiri1, Abdulmalik Alshehri1
1College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 14611, Saudi Arabia.
Background/Objectives:
Community-acquired pneumonia (CAP) is classified into typical and atypical forms, with Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila being the most common atypical pathogens and Streptococcus pneumoniae and Haemophilus influenzae the most common typical organisms. This study aimed to compare the prevalence, demographics, and clinical outcomes of hospitalized typical and atypical CAP patients.
Methods:
A cross-sectional study was conducted from January 2016 to June 2022 at two tertiary hospitals in Riyadh, Saudi Arabia. All inpatients diagnosed with CAP by imaging and clinical findings were included, excluding viral cases. Outcomes measured included pathogen testing and identification, hospitalization duration, ICU stay, and in-hospital mortality.
Results:
Among 1238 CAP hospitalizations, 65% underwent molecular testing, with atypical pathogens detected in 17 cases (2.09%). Mycoplasma pneumoniae was the most common organism. The cases had an almost equal male-to-female ratio. Mean hospitalization was 12 days overall versus 4 days for atypical pneumonia. Of 265 ICU admissions, none tested positive for atypical CAP. Overall mortality was 6.94%, with no deaths in atypical pneumonia positive patients.
Conclusions:
PCR molecular testing was performed in 65% of patients hospitalized with CAP, and atypical pneumonia organisms were uncommon in these patients, with Mycoplasma pneumoniae being the most common. Clinical outcomes were more favorable for these patients. Expanding molecular testing may improve pathogen detection and guide target management.
Insights
Atypical community-acquired pneumonia (CAP) is uncommon in hospitalized patients, with Mycoplasma pneumoniae being the most frequent cause. Patients with atypical CAP experienced shorter hospital stays and better outcomes, suggesting expanded molecular testing could improve diagnosis and treatment.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Community-acquired pneumonia (CAP) presents as typical or atypical forms.
- Common atypical pathogens include Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila.
- Typical pathogens commonly include Streptococcus pneumoniae and Haemophilus influenzae.
Purpose of the Study:
- To compare the prevalence, demographics, and clinical outcomes of hospitalized typical and atypical CAP patients.
- To assess the utility of molecular testing in identifying CAP pathogens.
Main Methods:
- A cross-sectional study was conducted from January 2016 to June 2022 in Riyadh, Saudi Arabia.
- Inclusion criteria: hospitalized patients with CAP diagnosed via imaging and clinical findings (excluding viral cases).
- Outcomes: pathogen testing, hospitalization duration, ICU stay, and in-hospital mortality.
Main Results:
- Atypical pathogens were detected in 2.09% of 1238 CAP hospitalizations, with Mycoplasma pneumoniae being most common.
- Patients with atypical pneumonia had significantly shorter mean hospitalizations (4 days) compared to overall CAP (12 days).
- No atypical CAP cases required ICU admission or resulted in mortality.
Conclusions:
- Atypical pneumonia organisms are infrequent causes of CAP in hospitalized patients, despite molecular testing in 65% of cases.
- Patients with atypical CAP demonstrated more favorable clinical outcomes.
- Increased utilization of molecular testing may enhance pathogen identification and guide targeted CAP management.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
Pneumonia I: Introduction

